SARGEN GREGORY
SEC insider (Form 3/4/5 filer). CIK 0001227835. Director at Protara Therapeutics, Inc. (TARA) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 15, 2026. Located in NEW YORK, NY.
Companies SARGEN GREGORY has filed insider reports for
- Protara Therapeutics, Inc. (TARA): Director
- Avid Bioservices, Inc. (CDMO): Director
SARGEN GREGORY
CIK: 0001227835
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 15, 2026TARA
Protara Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
31K shares- - Jun 12, 2025TARA
Protara Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
24K shares- - Feb 5, 2025CDMO
Avid Bioservices, Inc.
DispositionDirect36.4K shares- - Dec 14, 2024CDMO
Avid Bioservices, Inc.
ExerciseDirect26.8K shares- - Dec 14, 2024CDMO
Avid Bioservices, Inc.
AwardDirectRestricted Stock Units
8.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 15, 2026 |  TARA Protara Therapeutics, Inc. | Award Stock Option (Right to Buy) | 31,000 | - | - | Direct |
| Jun 12, 2025 | TARA Protara Therapeutics, Inc. | Award Stock Option (Right to Buy) | 24,000 | - | - | Direct |
| Feb 5, 2025 |  CDMO Avid Bioservices, Inc. | Disposition | 36,368 | - | - | Direct |
| Dec 14, 2024 | CDMO Avid Bioservices, Inc. | Exercise | 26,756 | - | $0 | Direct |
| Dec 14, 2024 | CDMO Avid Bioservices, Inc. | Award Restricted Stock Units | 8,147 | - | - | Direct |
1-5 of 5 transactions